NC

Nexthera Capital Portfolio holdings

AUM $120M
1-Year Est. Return 10.01%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+10.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$120M
AUM Growth
+$37.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$12.6M
2
+$7.21M
3
+$6.33M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$5.61M
5
CHRS icon
Coherus Oncology
CHRS
+$5.49M

Top Sells

1
+$9.5M
2
+$5.08M
3
+$4.18M
4
NVS icon
Novartis
NVS
+$3.83M
5
CBAY
Cymabay Therapeutics
CBAY
+$2.79M

Sector Composition

1 Healthcare 92.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
26
Heron Therapeutics
HRTX
$187M
– –
-388,623
KNSA icon
27
Kiniksa Pharmaceuticals
KNSA
$3.49B
– –
-67,692
BHC icon
28
Bausch Health
BHC
$2.06B
– –
-205,660
NVS icon
29
Novartis
NVS
$307B
– –
-50,587
SAGE
30
DELISTED
Sage Therapeutics
SAGE
– –
-6,200
DCPH
31
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-42,865
CBAY
32
DELISTED
Cymabay Therapeutics
CBAY
– –
-210,257
ACOR
33
DELISTED
Acorda Therapeutics
ACOR
– –
-1,290
CHMA
34
DELISTED
Chiasma, Inc. Common Stock
CHMA
– –
-203,948
STML
35
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-325,526
1
2